Piper Sandler on Kestra Medical Technologies (KMTS): 'We remain highly bullish on the name'

October 5, 2026 8:46 AM

Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $30.00 price target on Kestra Medical Technologies (NASDAQ: KMTS).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found